CoChat

Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

Open access
Bradley, Ellen R., Woolley, Joshua D. · 2017 · Neuroscience & Biobehavioral Reviews
Cited by 89

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

Abstract

HIGHLIGHTSStudies of oxytocin in schizophrenia have yielded mixed results.Study design and individual differences may account for this heterogeneity.Oxytocin may improve specific deficits not captured in many studies.Future studies should employ precise, objective outcomes to capture oxytocin effects. ABSTRACT Schizophrenia is a severe mental illness that causes major functional impairment. Current pharmacologic treatments are inadequate, particularly for addressing negative and cognitive symptoms of the disorder. Oxytocin, a neuropeptide known to moderate social behaviors, has been investigated as a potential therapeutic for schizophrenia in recent years. Results have been decidedly mixed, leading to controversy regarding oxytocin's utility. In this review, we outline several considerations for interpreting the extant literature and propose a focused agenda for future work that builds on the most compelling findings regarding oxytocin effects in schizophrenia to date. Specifically, we examine underlying causes of heterogeneity in randomized clinical trials (RCTs) conducted thus far and highlight the complexity of the human oxytocin system. We then review evidence of oxytocin's effects on specific deficits in schizophrenia, arguing for further study using objective, precise outcome measures in order to determine whether oxytocin has the potential to improve functional impairment in schizophrenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2017.05.007

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 121 references

Cited by

See all 89

Metadata

Authors
Bradley, E. R., & Woolley, J. D.
Venue
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Published
2017-09
Volume
80
Pages
36-56
ISSN
0149-7634 (ISSN-L)
OpenAlex
W2613328034
Cited by
89
References
121
FWCI
9.37
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward. https://app.cochat.ai/papers/10.1016/j.neubiorev.2017.05.007
The paper
Bradley, E. R., & Woolley, J. D. (2017). Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2017.05.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.